In addition, PF562271 at 50 mg/kg/day inhibited tumor growth in the H82-xenograft murine model and effectively suppressed tumor growth at 150 mg/kg/day, with substantial reductions in p-FAK and Ki67 levels (Fig. 7p–u). Here, PTK2 is linked to neoplasm.